Profile for Slovenia Patent: 2892900
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Slovenia Patent: 2892900
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| ⤷ Get Started Free | Sep 6, 2033 | Genzyme Corp | WAYRILZ | rilzabrutinib |
| ⤷ Get Started Free | Sep 6, 2033 | Genzyme Corp | WAYRILZ | rilzabrutinib |
| ⤷ Get Started Free | Sep 6, 2033 | Genzyme Corp | WAYRILZ | rilzabrutinib |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
